Harbor Capital Advisors, Inc. Ptc Therapeutics, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.38 Billion
- Q2 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 48,767 shares of PTCT stock, worth $2.21 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
48,767
Previous 40,725
19.75%
Holding current value
$2.21 Million
Previous $2.08 Million
14.8%
% of portfolio
0.1%
Previous 0.09%
Shares
9 transactions
Others Institutions Holding PTCT
# of Institutions
308Shares Held
80.1MCall Options Held
255KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA8.85MShares$401 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$352 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$351 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$214 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$213 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.24B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...